Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Santhera Pharmaceuticals Holding (SPHDF)

OTHER OTC:SPHDF

SPHDF

Santhera Pharmaceuticals Holding

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Santhera Pharmaceuticals Holding (SPHDF) Income Statement

31 Followers

Santhera Pharmaceuticals Holding Income Statement

Last quarter (Q2 2022), Santhera Pharmaceuticals Holding's total revenue was CHF―, a decrease of ― from the same quarter last year. In Q2, Santhera Pharmaceuticals Holding's net income was CHF―. See Santhera Pharmaceuticals Holding’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	-	CHF -1.59M	CHF 15.01M	CHF 75.38M	CHF 31.66M	CHF 22.94M
Cost of Revenue	-	CHF 3.77M	CHF 10.43M	CHF 5.45M	CHF 4.70M	CHF 4.10M
Gross Profit	-	CHF -5.36M	CHF 4.58M	CHF 69.93M	CHF 26.95M	CHF 18.84M
Operating Expense	-	CHF 51.53M	CHF 57.65M	CHF 80.37M	CHF 78.38M	CHF 69.29M
Operating Income	-	CHF -56.89M	CHF -53.08M	CHF -10.44M	CHF -51.42M	CHF -50.45M
Net Non Operating Interest Income Expense	-	CHF -6.42M	CHF -15.14M	CHF -6.07M	CHF -4.84M	CHF -3.77M
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	CHF -54.72M	CHF -67.46M	CHF -18.39M	CHF -53.86M	CHF -51.27M
Tax Provision	-	CHF 809.00K	CHF 203.00K	CHF 579.00K	CHF 322.00K	CHF 257.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	CHF -55.53M	CHF -67.66M	CHF -18.97M	CHF -54.19M	CHF -51.53M
Basic EPS	-	CHF -1.62	CHF -5.08	CHF -1.73	CHF -7.86	CHF -8.22
Diluted EPS	-	CHF -1.62	CHF -5.08	CHF -1.73	CHF -7.86	CHF -8.22
Basic Average Shares	-	CHF 34.17M	CHF 13.32M	CHF 10.99M	CHF 6.89M	CHF 6.27M
Diluted Average Shares	-	CHF 34.17M	CHF 13.32M	CHF 10.99M	CHF 6.89M	CHF 6.27M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	CHF 44.00K	CHF 16.00K	CHF 16.00K	CHF 859.00K	-
Total Expenses	-	CHF 55.29M	CHF 68.08M	CHF 85.82M	CHF 83.08M	CHF 73.40M
Net Income From Continuing And Discontinued Operation	-	CHF -55.53M	CHF -67.66M	CHF -18.97M	CHF -54.19M	CHF -51.53M
Normalized Income	-	CHF -62.89M	CHF -68.08M	CHF -18.63M	CHF -56.31M	CHF -53.45M
Interest Expense	-	CHF 16.42M	CHF 6.89M	CHF 6.08M	CHF 4.50M	CHF 3.84M
EBIT	-	CHF -38.29M	CHF -60.56M	CHF -12.31M	CHF -49.36M	CHF -47.43M
EBITDA	-	CHF -34.57M	CHF -53.43M	CHF -7.54M	CHF -45.62M	CHF -44.05M

Currency in CHF

Santhera Pharmaceuticals Holding Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing